4️⃣ sample size: consider up to 30% drop-out.
5️⃣ identify funding or logistical (e.g. virtual) opportunities to address reported barriers to participation (e.g. travel costs & distance).
4️⃣ sample size: consider up to 30% drop-out.
5️⃣ identify funding or logistical (e.g. virtual) opportunities to address reported barriers to participation (e.g. travel costs & distance).
1️⃣ logistics: consider challenges & solutions with multi-centre studies (e.g., how to integrate different clinical processes & care across centres).
2️⃣ eligibility: including an upper limit for the length of time since the patient has been listed for HTx
1️⃣ logistics: consider challenges & solutions with multi-centre studies (e.g., how to integrate different clinical processes & care across centres).
2️⃣ eligibility: including an upper limit for the length of time since the patient has been listed for HTx
Our response: publication of ➖ clinical trial data is critical (to reduce publication bias & research waste, inform future trial designs, & adherence to ethical reporting for patients who participated in the research).
Our response: publication of ➖ clinical trial data is critical (to reduce publication bias & research waste, inform future trial designs, & adherence to ethical reporting for patients who participated in the research).